Inhaled drug shows promise for rare lung disease combination
A therapeutic principle rooted in decades of pulmonary vascular research is entering a new stage of clinical development. The investigational inhaled drug mosliciguat, a soluble guanylate cyclase (sGC) ...
26 Sep 15:00 · Medical Xpress